EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ABCB1 Gene Polymorphisms and Their Contribution to Cognitive Decline in Mild Cognitive Impairment: A Next-Generation Sequencing Study

Omar Šerý, Kateřina Sheardová, Radka Dziedzinska, Tomáš Zeman, Martin Vyhnálek, Hana Marková, Jan Laczó, Jan Lochman iD, Kamila Vrzalová, Vladimir J Balcar, Jakub Hort

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 2025

DOI: 10.1093/gerona/glaf055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2025. Verfasst von Omar Šerý und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neurobiology and Molecular Psychiatry, Department of Biochemistry, Faculty of Science, Masaryk University, Brno, Czech Republic. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Polymorphism, Single Nucleotide. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Czech Health Research Council, Czech Republic (AZV ČR), EU-Next Generation EU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ABCB1 gene, encoding the ATP-dependent translocase ABCB1, plays a crucial role in the clearance of amyloid-beta (Aβ) peptides and the transport of cholesterol, implicating it in the pathogenesis of Alzheimer’s disease. The study aims to investigate the association between polymorphisms in the ABCB1 gene and cognitive decline in individuals with mild cognitive impairment (MCI), particularly focusing on language function. A longitudinal cohort study involving 1 005 participants from the Czech Brain Aging Study was conducted. Participants included individuals with Alzheimer’s disease, amnestic MCI, non-amnestic MCI, subjective cognitive decline, and healthy controls. Next-generation sequencing was utilized to analyze the entire ABCB1 gene. Cognitive performance was assessed using a comprehensive battery of neuropsychological tests, including the Boston Naming Test and the semantic verbal fluency test. Ten ABCB1 polymorphisms (rs55912869, rs56243536, rs10225473, rs10274587, rs2235040, rs12720067, rs12334183, rs10260862, rs201620488, and rs28718458) were significantly associated with cognitive performance, particularly in language decline among amnestic MCI patients. In silico analyses revealed that some of these polymorphisms may affect the binding sites for transcription factors (HNF-3alpha, C/EBPβ, GR-alpha) and the generation of novel exonic splicing enhancers. Additionally, polymorphism rs55912869 was identified as a potential binding site for the microRNA hsa-mir-3163. Our findings highlight the significant role of ABCB1 polymorphisms in cognitive decline, particularly in language function, among individuals with amnestic MCI. These polymorphisms may influence gene expression and function through interactions with miRNAs, transcription factors, and alternative splicing mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionPolymorphism, Single NucleotideHumansMaleFemaleAgedATP Binding Cassette Transporter, Subfamily BLongitudinal StudiesHigh-Throughput Nucleotide SequencingNeuropsychological TestsAged, 80 and overAlzheimer DiseaseCzech Republic

Stichwörter der Autor:innen

ATP-binding cassette transportersATP-dependent translocaseAlzheimer’s diseaseDNA polymorphismsLanguage decline

Substanzen

ABCB1 protein, humanATP Binding Cassette Transporter, Subfamily B

Autor:innen und Institutionen

  • Laboratory of Neurobiology and Molecular Psychiatry, Department of Biochemistry, Faculty of Science, Masaryk University, Brno, Czech Republic.
  • Laboratory of Neurobiology and Pathological Physiology, Institute of Animal Physiology and Genetics, Czech Academy of Sciences, Brno, Czech Republic.
  • International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
  • First Neurology Department, St. Anne's University Hospital Brno, Brno, Czech Republic.
  • Memory Clinic, Department of Neurology, Charles University, Second Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.
  • Neuroscience Theme, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

ORCID-Profile: Jan Lochman

Förderung

  • Czech Health Research Council
  • Czech Republic (AZV ČR)
  • EU-Next Generation EU
  • EU—Next Generation EU

Zitieren

APA

Šerý, O., Sheardová, K., Dziedzinska, R., Zeman, T., Vyhnálek, M., Marková, H., Laczó, J., Lochman, J., Vrzalová, K., Balcar, V. J., & Hort, J. (2025). ABCB1 Gene Polymorphisms and Their Contribution to Cognitive Decline in Mild Cognitive Impairment: A Next-Generation Sequencing Study. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/glaf055

Vancouver

Šerý O, Sheardová K, Dziedzinska R, Zeman T, Vyhnálek M, Marková H, et al. ABCB1 Gene Polymorphisms and Their Contribution to Cognitive Decline in Mild Cognitive Impairment: A Next-Generation Sequencing Study. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2025. doi:10.1093/gerona/glaf055

BibTeX
@article{er2025,
  author = {Šerý, Omar and Sheardová, Kateřina and Dziedzinska, Radka and Zeman, Tomáš and Vyhnálek, Martin and Marková, Hana and Laczó, Jan and Lochman, Jan and Vrzalová, Kamila and Balcar, Vladimir J and Hort, Jakub},
  title = {ABCB1 Gene Polymorphisms and Their Contribution to Cognitive Decline in Mild Cognitive Impairment: A Next-Generation Sequencing Study},
  journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
  year = {2025},
  doi = {10.1093/gerona/glaf055}
}
Kostenlos starten →